Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 29 M36 M38 M39 M44 M 157 M Research & development 182 M190 M179 M194 M195 M 758 M Operating income -211 M-230 M-222 M-238 M-244 M -934 M Non-Operating Income, Total 12 M13 M16 M15 M22 M 66 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 00000 0 Unusual income/expense 12 M13 M16 M15 M22 M 66 M Pretax income -208 M-201 M-201 M-206 M-223 M -831 M Equity in earnings ————— — Taxes 00000 0 Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -208 M-201 M-201 M-206 M-223 M -831 M Discontinued operations ————— — Net income -208 M-201 M-201 M-206 M-223 M -831 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -208 M-201 M-201 M-206 M-223 M -831 M Basic earnings per share (Basic EPS) -0.12-0.11-0.11-0.1-0.11 -0.43 Diluted earnings per share (Diluted EPS) -0.12-0.11-0.11-0.1-0.11 -0.43 Average basic shares outstanding 1.74 B1.78 B1.89 B1.84 B1.95 B — Diluted shares outstanding 1.74 B1.78 B1.89 B1.84 B1.95 B — EBITDA -205 M-225 M-216 M-225 M-238 M -904 M EBIT -211 M-230 M-222 M-238 M-244 M -934 M Cost of revenue 05 M6 M6 M6 M 23 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 6 M5 M6 M13 M6 M 30 M